Country Guide: Filing a Patent in the United States

The United States Patent and Trademark Office is the most litigated, most analysed, and most commercially significant patent jurisdiction in the world. For most technology inventions, US patent protection is not optional — it is the anchor of any global IP strategy. The US market is the world's largest consumer economy; the US patent system is the most frequently used mechanism for technology licensing; and US patent litigation, despite its cost and complexity, produces some of the largest IP damages awards on earth.

This guide gives you a practical, detailed understanding of the US patent system — how it works, where it differs from other major jurisdictions, the specific strategic choices that matter, and the hard realities that most patent guides do not discuss.

The Hard Truth About US Patents

More than 350,000 US patent applications are filed each year. About half are granted. Of those granted, fewer than 5% ever generate meaningful revenue for their owners. The gap between filing a patent application and creating commercial value from it is wide, and most inventors underestimate it.

US patents fail commercially for predictable reasons:

• Claims that were narrowed so much during prosecution that they no longer cover competitor products
• Patents in technology areas that turn out not to be commercially significant
• Patents that are never enforced because the owner cannot afford litigation
• Patents on inventions that solve problems no one actually has

This is not an argument against patenting. It is an argument for strategic patenting — filing patents that are commercially grounded, claim-drafted with enforcement in mind, and connected to a viable commercialisation plan. A US patent is a tool, not a trophy.

Overview of US Patent Types

Utility Patents

The standard US patent. Protects the function, mechanism, process, or composition of an invention.

• Term: 20 years from the filing date of the non-provisional application
• Patent Term Adjustment (PTA): If USPTO delays cause prosecution to extend beyond 3 years from filing, additional term is added to compensate. PTA of 1–3 years is common for complex applications.
• Patent Term Extension (PTE): Available for FDA-regulated products (drugs, medical devices) to compensate for time lost in regulatory approval. Up to 5 years.
• Maintenance fees: Due at 3.5, 7.5, and 11.5 years after grant. Missing fees causes lapse.
• Examination: Full substantive examination

Design Patents

Protects the ornamental appearance of a product.

• Term: 15 years from grant (for applications filed on or after May 13, 2015, under the Patent Law Treaties Implementation Act of 2012, aligning with the Hague Agreement)
• No maintenance fees required
• Examination: Full substantive examination (all US design patents are examined before grant)

See our dedicated guide: Design Patents and Registered Designs: A Global Guide

Plant Patents

Protects asexually reproduced plant varieties. Highly specialised and outside the scope of most inventors.

What Is and Is Not Patentable in the US

US patent eligibility under 35 USC §101 has been the most contentious area of US patent law for the past decade, particularly for software, business methods, and diagnostic methods.

Eligible subject matter (broadly): Any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof.

Judicially created exclusions:

• Abstract ideas (including mathematical concepts, mental processes, and methods of organising human activity)
• Laws of nature
• Natural phenomena

The Supreme Court's Alice Corp. v. CLS Bank International (2014) decision dramatically changed software patent eligibility, requiring that software claims be directed to a specific technical improvement rather than merely implementing an abstract idea on a generic computer. Post-Alice §101 rejections became endemic — at their peak, some technology units were rejecting over 90% of applications on §101 grounds.

The Alice two-step test:

1. Is the claim directed to a patent-ineligible concept (abstract idea, law of nature, natural phenomenon)?
2. If yes, does the claim contain an "inventive concept" — something that transforms the claim into significantly more than the abstract idea itself?

Practical implications for inventors:

• Software claims must be tied to specific technical improvements with concrete, measurable results
• Business method claims are very difficult to prosecute post-Alice
• Diagnostic method claims must be carefully structured (product claims often fare better than method claims in the medical field)
• Physical product inventions (mechanical, chemical, hardware) are far less affected by §101 issues

Biotech and pharmaceutical special considerations: Claims to natural products — genes, proteins, naturally occurring compounds — must claim something meaningfully different from what exists in nature. Isolated but otherwise unmodified natural products are generally not eligible (Association for Molecular Pathology v. Myriad Genetics, 2013).

The US Application Process in Detail

Provisional Patent Applications

The US provisional application is one of the most useful — and most misused — tools in patent prosecution.

What it does:

• Establishes a US priority date for 12 months
• Allows use of "patent pending"
• Does not get examined, never becomes a patent
• Costs $350 in basic government filing fees for large entities, $140 for small entities, or $70 for micro entities (as of the January 2025 fee schedule — verify current fees at uspto.gov before filing, as the USPTO updates fees periodically)

The misuse: Many inventors treat a provisional as an excuse to file quickly and sloppily. Because provisionals are not examined, the quality bar feels lower. But the quality of the provisional determines the scope of the non-provisional claims that can benefit from the provisional's priority date. A provisional that describes only the preferred embodiment — without alternatives, variations, and different aspects of the invention — limits what can be claimed in the non-provisional.

Best practice: Write the provisional as if it will become the non-provisional specification. Describe every embodiment, alternative, and variation you can conceive of. Include drawings. Draft at least rough claim language. The 12-month window is for testing the market and refining — not for finishing the disclosure.

Non-Provisional Patent Applications

Formal requirements:

Specification: Must include a written description of the invention, a best mode disclosure (the inventor's best known way of practicing the invention at filing), and claims. The specification must enable a skilled person to make and use the invention.

Claims: The legal boundary of protection. Independent claims define the broadest scope; dependent claims add specific features. USPTO base fees include up to 20 total claims and 3 independent claims; additional claims incur per-claim fees.

Drawings: Required when necessary to understand the invention (almost always for mechanical and electrical inventions). USPTO drawing rules are detailed and strictly enforced. See: Patent Drawings: A Complete Guide

Abstract: 150 words or fewer summarising the invention.

Oath or declaration: Signed by each inventor declaring that they believe themselves to be the original inventor of the claimed subject matter.

Entity size and fees:

Micro entity status provides substantial savings. Verify eligibility carefully — incorrect claim of micro entity status can result in penalties.

Track One Prioritised Examination

For applicants who need faster examination, the USPTO offers Track One — a prioritised examination program that typically achieves final disposition (allowance or final rejection) within 12 months of filing, compared to the standard 18–24 months.

Cost: USD $1,806 additional fee for small entities ($4,515 for large entities, $903 for micro entities — as of the January 2025 fee schedule) Application limit: 10,000 Track One requests accepted per fiscal year (applications are limited, so file early if this is your plan) Strategic use: Particularly valuable for inventors in fast-moving technology areas where competitors are filing rapidly, or for licensing negotiations where a granted patent provides significantly more leverage than a pending application

Filing Electronically: EFS-Web and Patent Center

All US patent applications should be filed electronically through Patent Center (patentcenter.uspto.gov). Paper filing is subject to a surcharge and slower processing. Electronic filing provides:

• Immediate confirmation of receipt with timestamp
• Electronic status monitoring
• Secure document upload

Prosecution: What Happens After Filing

Publication

Unless the applicant files a non-publication request (available only for applications not filed in any foreign country), the application is published 18 months after the earliest claimed priority date. Once published, the application is publicly available — competitors can read your specification and pending claims.

The non-publication request: If you are filing only in the US and want to maintain confidentiality as long as possible, you can request non-publication at filing. The application will only become public if and when it grants. The trade-off: you cannot claim foreign priority for published foreign counterparts if a non-publication request is in effect.

Examination: The Office Action Cycle

First Office Actions typically issue 12–18 months after filing for standard prosecution; faster for Track One. The vast majority of applications receive at least one Office Action — in some technology units, the initial allowance rate without an Office Action is under 10%.

The most common rejections:

§102 — Anticipation: The examiner has found a single prior art reference that discloses every element of your claim. Response: argue the reference doesn't actually disclose all elements (common when the examiner has misread the reference), or amend the claims to add a distinguishing element.

§103 — Obviousness: The examiner combines two or more references to argue your invention is obvious. Response: argue there was no motivation to combine the references; argue the combination teaches away from the invention; argue unexpected results; or amend claims to add non-obvious distinguishing elements.

§101 — Subject Matter Eligibility: Particularly common for software, AI, and diagnostic method claims. Response: amend claims to emphasise the specific technical improvement achieved; argue the claim is directed to a practical application with concrete, measurable results; provide a technical explanation in the remarks of how the claim improves the functioning of a computer or technical process.

§112(a) — Enablement/Written Description: The specification does not adequately support the claimed invention. Response: point to specific specification passages that demonstrate support; amend claims to match the described embodiments; in some cases, provide a declaration from the inventor or an expert.

§112(b) — Indefiniteness: Claim language is unclear. Response: amend the claim to replace the indefinite term with precise language; argue the term has a clear and established meaning in the art.

A Real Prosecution Scenario

Consider an inventor who filed a US patent application for a self-regulating heating element for consumer appliances. The first Office Action arrived 16 months after filing with three rejections:

Rejection 1: §103 obviousness — the examiner combined two references (a heating element patent from 2008 and a temperature control circuit patent from 2015) to argue the combination rendered claim 1 obvious.

Rejection 2: §112(b) indefiniteness — the term "substantially consistent temperature" in claim 1 was found indefinite without a specific threshold or range.

Rejection 3: §101 — a method claim (claim 12) was found directed to an abstract idea (the idea of maintaining temperature through feedback).

The attorney's response:

• Rejection 1: Argued that the 2008 reference taught away from the combination — the reference's design explicitly rejected feedback regulation for safety reasons — and that a skilled person would not have combined it with the 2015 control circuit for this reason. Also amended claim 1 to add a specific structural feature (a bimetallic strip sensor) that appeared in neither reference.

• Rejection 2: Amended claim 1 to specify "within ±2°C of a target temperature" replacing "substantially consistent." This change, while narrow, was supported by the specification.

• Rejection 3: Amended claim 12 to recite specific hardware components (the bimetallic strip sensor and a switching circuit) and a measurable technical effect (reducing energy consumption by at least 15% compared to an on/off thermostat control). This amendment transformed the abstract idea into a claim directed to a specific technical improvement.

Result: A second Office Action issued, allowing claims 1–11 but maintaining the §101 rejection on amended claim 12. A further response and examiner interview led to a narrow allowance of claim 12 with additional hardware limitations.

The lesson: Prosecution is a negotiation. The initial rejections were not the end — they were the opening of a dialogue. The right response required understanding the examiner's specific objections, not just generic arguments.

Interview Practice

The USPTO encourages telephone and video interviews between applicants and examiners. An examiner interview — typically a 20–30 minute call — can resolve in minutes what might take months of written exchange.

Request an interview after the first Office Action if the issues are complex or if there appears to be a misunderstanding of the invention. Come to the interview with a proposed claim amendment and a clear articulation of how your invention differs from the cited prior art.

Statistics consistently show that applications where interviews are conducted have higher allowance rates than those conducted entirely by written correspondence. Examiners are people — they respond to genuine engagement.

After Allowance: Issue Fees and Publication

When the examiner issues a Notice of Allowance, you have 3 months to pay the issue fee ($1,200 for small entity as of 2025 fees) or the patent lapses. Once paid, the patent typically issues 4–8 weeks later.

The issued patent is published in the Official Gazette and becomes publicly searchable in USPTO databases. The patent number appears on the publication and should be used for patent marking on products.

Post-Grant Proceedings: PTAB

The Patent Trial and Appeal Board (PTAB) administers post-grant patent challenges — mechanisms allowing third parties to challenge the validity of a granted US patent without the cost and complexity of district court litigation.

Inter Partes Review (IPR)

The most commonly used post-grant mechanism. A third party petitions PTAB to review issued patent claims on grounds of prior art (§102 and §103 only — not §101 or §112). If PTAB institutes review, a trial is conducted before a panel of three administrative patent judges.

Statistics: IPR petitions are filed frequently against patents involved in or anticipated in litigation. Approximately 50–60% of challenged claims are found unpatentable in instituted proceedings. The presence of IPR creates uncertainty around any granted US patent and affects its licensing and litigation value.

Implication for inventors: A US patent that has survived an IPR challenge is substantially more valuable than one that has not been tested. "IPR-proof" patents — those with strong prior art searches conducted before filing, broad claims grounded in clearly distinguishable invention, and prosecution records that do not contain statements unnecessarily limiting claim scope — command premium valuation in licensing markets.

Timing: An IPR petition must be filed within 1 year of service of a complaint for patent infringement. This time bar protects patent owners from indefinite exposure to IPR after being sued.

Post-Grant Review (PGR)

Available only within 9 months of the patent grant date. Allows challenge on any grounds of invalidity, including §101 and §112. Less commonly used than IPR.

ITC Section 337: Blocking Infringing Imports

For inventors whose products are manufactured overseas — which is most of them — the International Trade Commission (ITC) offers a powerful enforcement mechanism that most inventor guides overlook entirely.

Section 337 of the Tariff Act allows a US patent holder to file a complaint with the ITC alleging that imported products infringe their patent. If the ITC finds infringement, it can issue an exclusion order directing US Customs to block the infringing products at the border — preventing them from entering the country at all.

Why the ITC matters for independent inventors:

The ITC is often more practical than district court litigation for three reasons. First, it is fast — investigations are completed within 12–18 months, compared to 2–4 years for typical district court patent cases. Second, you do not need to prove damages — the remedy is an exclusion order, not a money judgment, so the financial burden of proving lost profits or reasonable royalties does not apply. Third, an exclusion order is enforced by US Customs at every port of entry, effectively creating a nationwide injunction.

Limitations: The ITC cannot award monetary damages. For damages, you must file a parallel action in district court. The ITC also requires a "domestic industry" — you must show that you are commercially exploiting the patent in the US (manufacturing, licensing, or significant engineering/R&D investment). Simply holding a patent without commercialisation activity may not satisfy this requirement.

Cost: An ITC investigation is expensive — typically $1M–$3M for the complainant, comparable to district court litigation. However, for inventors facing systematic importation of infringing products (particularly from China), the ITC's speed and border enforcement powers can be decisive. Some patent litigation firms take ITC cases on contingency for strong patents.

Strategic use: File the ITC complaint and a parallel district court action simultaneously. The ITC provides fast injunctive relief; the district court provides damages. Together, they create maximum pressure on the infringer.

US Patent Strategy: Key Decisions

Building a Continuation Family

The US system's continuation practice — filing new applications that claim priority to the original while pursuing different or broader claims — is one of the most powerful tools available to patent holders. See our dedicated guide: Patent Continuation Strategy: Keeping Your Patent Family Alive

The key strategic point: never let a commercially important patent grant without having a continuation on file or in the plan. The continuation preserves prosecution options and keeps the patent family alive.

Prosecution History Management

Every statement made during prosecution becomes part of the prosecution history, which courts use to interpret claim scope. The principle of prosecution history estoppel means that narrowing amendments or arguments made to overcome prior art limit how broadly claims can be interpreted in litigation.

Strategic discipline: argue rather than amend when possible. Amendments narrow claims and create estoppel; arguments (if successful) preserve the original scope. When amendment is necessary, narrow as minimally as possible.

Freedom to Operate Before Launch

A freedom-to-operate (FTO) analysis — conducted by a patent attorney — examines whether your product or process would infringe any valid, unexpired US patents owned by others. An FTO analysis does not guarantee safety (it cannot cover patents that have not yet published), but it identifies known risks and allows them to be addressed before investment in production.

For any product with significant commercial investment, conduct an FTO analysis before committing to production tooling and manufacturing. Discovering an infringement issue after product launch — when you have inventory, customer commitments, and production contracts — is far more expensive than discovering it before.

Costs: A Realistic Breakdown

All government fees shown are small entity rates as of the January 2025 USPTO fee schedule. Fees change periodically — always verify current fees at USPTO Fee Schedule before filing. Micro entities pay 80% less than large entity fees; small entities pay 60% less.

These ranges reflect attorney fees for competent but not premium-market representation. Large-firm US patent work can cost 2–3× these figures. Quality does not always scale linearly with price — an experienced boutique patent attorney with relevant technical background will often produce better prosecution outcomes than a large-firm associate at higher rates.

Sources

1. United States Patent and Trademark Office (USPTO) — Official patent office; filing procedures, Patent Center, and examination guidance
2. USPTO Fee Schedule — Current government fees for all entity sizes
3. 35 U.S.C. — Patent Law — Statutory framework for US patent law
4. WIPO — United States Country Profile — International treaty memberships and IP office information
5. USPTO Patent Trial and Appeal Board (PTAB) — Post-grant proceedings including IPR and PGR
6. U.S. International Trade Commission (ITC) — Section 337 investigations and exclusion orders

Information current as of April 2026. Patent fees, timelines, and office procedures change — verify with the national patent office before filing.